Compass Point Initiates Coverage On Brookdale Senior Living with Buy Rating, Announces Price Target of $22

Can Ensign Group's Operating Model Drive Growth Beyond Acquisitions?

The Ensign Group demonstrates strong organic growth momentum with same-facility skilled nursing revenues rising 6.6% year-over-year, driven by higher occupancy at 84.1% and improved clinical outcomes 23% better than state averages. The company's decentralized operating model enables local teams to optimize existing facilities, potentially reducing reliance on acquisitions and supporting more durable long-term earnings growth.

Brookdale Senior Living shares are trading lower after the company reported worse-than-expected Q2 sales results. Also, Barclays lowered its price target on the stock from $18 to $17.

Barclays Maintains Overweight on Brookdale Senior Living, Lowers Price Target to $17

Barclays analyst Andrew Mok maintains Brookdale Senior Living (NYSE:BKD) with a Overweight and lowers the price target from $18 to $17.

Brookdale Senior Living Q2 EPS $0.10 Beats $(0.06) Estimate, Sales $718.583M Miss $732.785M Estimate

Brookdale Senior Living (NYSE:BKD) reported quarterly earnings of $0.10 per share which beat the analyst consensus estimate of $(0.06) by 300 percent. This is a 155.56 percent increase over losses of $(0.18) per share